https://www.llamalab.ai/blog/dupixent-ctcl-lymphoma-emerging-mdl-2026 LlamaLab en 2026-06-08T00:00:00.000Z Dupixent CTCL Lawsuits: The Next Emerging MDL https://www.llamalab.ai/optimized/blogs/dupixent-ctcl-lymphoma-emerging-mdl-2026.webp Dupixent CTCL Lawsuits: The Next Emerging MDL https://www.llamalab.ai/blog/talc-litigation-verdicts-split-filings-surge-2026 LlamaLab en 2026-06-05T00:00:00.000Z Talc Verdicts Split as Filings Surge 47% in 2025 https://www.llamalab.ai/optimized/blogs/talc-litigation-verdicts-split-filings-surge-2026.webp Talc Verdicts Split as Filings Surge 47% in 2025 https://www.llamalab.ai/blog/byheart-infant-formula-mdl-3178-2026 LlamaLab en 2026-06-03T00:00:00.000Z ByHeart Formula Botulism Cases Become MDL-3178 https://www.llamalab.ai/optimized/blogs/byheart-infant-formula-mdl-3178-2026.webp ByHeart Formula Botulism Cases Become MDL-3178 https://www.llamalab.ai/blog/ny-tort-reform-hochul-budget-serious-injury-2026 LlamaLab en 2026-05-18T00:00:00.000Z Hochul Tort Reform Tightens NY Injury Threshold https://www.llamalab.ai/optimized/blogs/ny-tort-reform-hochul-budget-2026.webp Hochul Tort Reform Tightens NY Injury Threshold https://www.llamalab.ai/blog/ai-courts-efficiency-progress LlamaLab en 2026-05-17T00:00:00.000Z AI Courts and the Risk of Efficient Stagnation https://www.llamalab.ai/optimized/blogs/ai-courts-efficiency-progress.webp AI Courts and the Risk of Efficient Stagnation